Telo Genomics Corp.
TELO.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -438.80K | -405.30K | -437.90K | -449.50K | -613.90K |
| Total Depreciation and Amortization | 2.30K | 4.00K | 6.40K | 7.30K | 7.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -28.00K | -7.40K | 45.80K |
| Change in Net Operating Assets | 146.50K | 58.50K | 90.90K | 18.10K | 58.50K |
| Cash from Operations | -289.90K | -342.80K | -368.60K | -431.50K | -501.80K |
| Capital Expenditure | -- | -- | -1.70K | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -1.70K | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | -22.50K | -- |
| Issuance of Common Stock | 2.55M | -- | 650.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -220.00K | -200.00 | -38.20K | 0.00 | 0.00 |
| Cash from Financing | 1.66M | -100.00 | 447.10K | -16.70K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.37M | -342.90K | 76.80K | -448.20K | -501.80K |
